News
AstraZeneca PLC - AstraZeneca:high level results of the ARCTIC trial
RNS Number: 8538 L AstraZeneca PLC 24 April 2018 24 April 2018 07:00 BST. ASTRAZENECA REPORTS RESULTS FROM THE ARCTIC TRIAL IN THIRD-LINE NON-SMALL CELL LUNG CANCER. AstraZeneca and MedImmune, its global biologics research and development arm, today announced high-level results from the Phase III ARCTIC trial in patients with locally-advanced or...
RNS Number: 8538 L AstraZeneca PLC 24 April 2018 24 April 2018 07:00 BST. ASTRAZENECA REPORTS RESULTS FROM THE ARCTIC TRIAL IN THIRD-LINE NON-SMALL CELL LUNG CANCER. AstraZeneca and MedImmune, its global biologics research and development arm, today announced high-level results from the Phase III ARCTIC trial in patients with locally-advanced or...